Effects of a 1.94% sulfonic acid teat dip and a 1% iodophor teat dip on teat canal infections in lactating dairy cows.
Sixty-three cows were used in a natural exposure trial for 1 yr to determine the effects of a 1.94% linear dodecyl benzene sulfonic acid and a 1% iodophor teat dip on teat canal and intramammary infections. Overall, total teat canal infections increased 28.9% and total intramammary infections increased 30% in quarters dipped with the linear dodecyl benzene sulfonic acid compared with a 14.3% increase in teat canal infections and a 17.4% decrease in intramammary infections for the iodophor group. Higher frequencies were observed for teat canal and intramammary infections caused by Staphylococcus epidermidis in the linear dodecyl benzene sulfonic acid group. Staphylococcus hyicus was the predominant organism isolated from teat canal and intramammary infections in the iodophor group. No difference was observed between the two teat dips in the persistence of Staphylococcus aureus teat canal infections. A greater number of S. hyicus teat canal infections persisted in the iodophor group, whereas teat canal infections produced by S. epidermidis and Staphylococcus xylosus persisted longer in the sulfonic acid group. Results of this study indicated that use of a linear dodecyl benzene sulfonic acid teat dip for 1 yr was not associated with increased S. aureus teat canal infections and intramammary infections. However, linear dodecyl benzene sulfonic acid appeared to affect the distribution of coagulase-negative staphylococci isolated from teat canal infections and intramammary infections.
Watts
J L
JL
Mastitis Research Laboratory, Louisiana State University Agricultural Center, Homer 71040.
Nickerson
S C
SC
Boddie
R L
RL
Ray
C H
CH
D000287:Administration, Topical; D000818:Animals; D001557:Benzenesulfonates / Q000008:administration & dosage / Q000627:therapeutic use*; D002417:Cattle; D005260:Female; D007466:Iodophors / Q000008:administration & dosage / Q000627:therapeutic use*; D008321:Mammary Glands, Animal / Q000382:microbiology; D008414:Mastitis, Bovine / Q000517:prevention & control*; D013203:Staphylococcal Infections / Q000517:prevention & control / Q000662:veterinary*; D013501:Surface-Active Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D001557:Benzenesulfonates; D007466:Iodophors; D013501:Surface-Active Agents; C001114:dodecylbenzenesulfonic acid